PSMα3 structure
|
Common Name | PSMα3 | ||
|---|---|---|---|---|
| CAS Number | 1001405-52-2 | Molecular Weight | 2635.13 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C128H192N28O30S | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of PSMα3PSMα3 is a peptide for manipulating DCs to become tolerogenic for DC vaccination strategies. PSMα3 penetrates and modulates human monocyte-derived DCs by altering the TLR2- or TLR4-induced maturation, inhibiting pro- and anti-inflammatory cytokine production and reducing antigen uptake. PSMα3 is an important toxin released by the most virulent strains of methicillin-resistant Staphylococcus aureus (MRSA)[1][2]. |
| Name | PSMα3 |
|---|
| Description | PSMα3 is a peptide for manipulating DCs to become tolerogenic for DC vaccination strategies. PSMα3 penetrates and modulates human monocyte-derived DCs by altering the TLR2- or TLR4-induced maturation, inhibiting pro- and anti-inflammatory cytokine production and reducing antigen uptake. PSMα3 is an important toxin released by the most virulent strains of methicillin-resistant Staphylococcus aureus (MRSA)[1][2]. |
|---|---|
| Related Catalog | |
| References |
| Molecular Formula | C128H192N28O30S |
|---|---|
| Molecular Weight | 2635.13 |